Literature DB >> 28986351

The Council of Europe should not reaffirm the ban on germline genome editing in humans.

Peter Sykora1, Arthur Caplan2.   

Abstract

Entities:  

Year:  2017        PMID： 28986351      PMCID： PMC5666594          DOI： 10.15252/embr.201745246

Source DB:  PubMed          Journal:  EMBO Rep        ISSN： 1469-221X            Impact factor:   8.807


× No keyword cloud information.
  1 in total

1.  Enhanced proofreading governs CRISPR-Cas9 targeting accuracy.

Authors:  Janice S Chen; Yavuz S Dagdas; Benjamin P Kleinstiver; Moira M Welch; Alexander A Sousa; Lucas B Harrington; Samuel H Sternberg; J Keith Joung; Ahmet Yildiz; Jennifer A Doudna
Journal:  Nature       Date:  2017-09-20       Impact factor: 49.962
  1 in total
  5 in total

1.  Gene Editing, the Mystic Threat to Human Dignity.

Authors:  Vera Lúcia Raposo
Journal:  J Bioeth Inq       Date:  2019-03-18       Impact factor: 1.352

2.  Human dignity and gene editing: Using human dignity as an argument against modifying the human genome and germline is a logical fallacy.

Authors:  Iñigo de Miguel Beriain
Journal:  EMBO Rep       Date:  2018-09-20       Impact factor: 8.807

3.  Germline gene therapy is compatible with human dignity.

Authors:  Peter Sykora; Arthur Caplan
Journal:  EMBO Rep       Date:  2017-11-15       Impact factor: 8.807

4.  The Council of Europe and the prohibition on human germline genome editing.

Authors:  Françoise Baylis; Lisa Ikemoto
Journal:  EMBO Rep       Date:  2017-11-15       Impact factor: 8.807

5.  Getting serious about the challenge of regulating germline gene therapy.

Authors:  Arthur Caplan
Journal:  PLoS Biol       Date:  2019-04-30       Impact factor: 8.029
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.